According to a new report, published by KBV research, The Global Amniotic Products Market size is expected to reach $1.6 billion by 2030, rising at a market growth of 7.4% CAGR during the forecast period.
The Dehydrated Amniotic Membranes segment is experiencing a CAGR of 8.7% during (2023 - 2030). Usually, venous and pressure leg ulcers, as well as a variety of surgical wounds, are treated with dehydrated amniotic membranes. These are typically applied as biological bandages to aid with healing. Dehydrated amniotic membranes that are commercially available include PalinGen, FlGraft, AmbioDisk, and AmnioFix. Due to qualities including their capacity to preserve a watertight seal, limit inflammatory reactions, and stop the spread of disease, these membranes are also commonly utilized in treating and caring for surgical wounds and incisions.
The Wound Care segment is leading the Global Amniotic Products Market by Application in 2022; thereby, achieving a market value of $601.1 Million by 2030. Amniotic membrane products are widely used as wound dressing for chronic wounds such as non-healing ulcers and burns. Cytokines and other bioactive substances found in the amniotic membrane encourage tissue regeneration and lessen inflammation, which helps in the healing process.
The Others segment is showcasing a CAGR of 8.1% during (2023 - 2030). The presence of skilled healthcare professionals in clinics and other such healthcare facilities is the major factor supporting the segment’s growth. Further, the market is witnessing growth in this segment as a result of the rising number of clinics in both urban and rural areas.
The North America region dominated the Global Amniotic Products Market by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $664 Million by 2030. The Europe region is poised to grow at a CAGR of 6.9% during (2023 - 2030). Additionally, The Asia Pacific region would witness a CAGR of 8.3% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/amniotic-products-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of MiMedx Group, Inc., Integra LifeSciences Holdings Corporation, Organogenesis Holdings, Inc., Amnio technology LLC, Alliqua Biomedical, Inc., Human Regenerative Technologies, LLC (Skye Biologics Holdings Company), Corza Ophthalmology (Corza Medical, Inc.), BioTissue Holdings, Inc., Applied Biologics LLC
By Type
By Application
By End User
By Geography
Companies Profiled
Unique Offerings 
